Karah Parschauer

Insider Reports History

Entity: Individual
Location: 60 Leveroni Court, Novato, CA
Signature: /s/ Jeffrey J. Plumer, as attorney-in-fact for Karah Parschauer
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karah Parschauer:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Ultragenyx Pharmaceutical Inc.	EVP and Chief Legal Officer	Common Stock	75.3K	$3.17M	$42.10	Mar 3, 2025	Direct
Evolus, Inc.	Director	Common Stock	32.2K	$418K	$12.99	Mar 12, 2025	Direct
Tenaya Therapeutics, Inc.	Director	Stock Option (Right to buy)	34K			Oct 18, 2024	Direct
Anebulo Pharmaceuticals, Inc.	Director	Stock Option (right to buy)	30.4K			Apr 21, 2022	Direct
Ultragenyx Pharmaceutical Inc.	EVP and Chief Legal Officer	Stock Option (Right to Buy)	26.1K			Mar 1, 2025	Direct
Arcturus Therapeutics Holdings Inc.	Director	Stock Option (right to buy)	15K			Jun 18, 2021	Direct
Evolus, Inc.	Director	Stock Option (Right to Buy)	11.1K			Mar 7, 2025	Direct

Previous1Next

Showing 1 to 7 of 7 entries

Insider Reports Filed by Karah Parschauer

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
EOLS	Evolus, Inc.	Mar 12, 2025	1	-$167K	4	Mar 14, 2025	Director
EOLS	Evolus, Inc.	Mar 7, 2025	2	$0	4	Mar 11, 2025	Director
RARE	Ultragenyx Pharmaceutical Inc.	Mar 1, 2025	2	-$541K	4	Mar 4, 2025	EVP and Chief Legal Officer
RARE	Ultragenyx Pharmaceutical Inc.	Feb 27, 2025	4	-$128K	4	Mar 3, 2025	EVP and Chief Legal Officer
TNYA	Tenaya Therapeutics, Inc.	Oct 18, 2024	1	$0	4	Oct 21, 2024	Director
RARE	Ultragenyx Pharmaceutical Inc.	Jun 12, 2024	1	-$441K	4	Jun 12, 2024	EVP and Chief Legal Officer
RARE	Ultragenyx Pharmaceutical Inc.	Mar 1, 2024	4	-$202K	4	Mar 5, 2024	EVP and Chief Legal Officer
EOLS	Evolus, Inc.	Feb 7, 2024	2	$0	4	Feb 9, 2024	Director
EOLS	Evolus, Inc.	Jan 30, 2024	1	-$157K	4	Feb 2, 2024	Director
TNYA	Tenaya Therapeutics, Inc.	Jun 9, 2023	1	$0	4	Jun 12, 2023	Director
RARE	Ultragenyx Pharmaceutical Inc.	May 4, 2023	1	-$197K	4	May 5, 2023	EVP and Chief Legal Officer
RARE	Ultragenyx Pharmaceutical Inc.	Mar 1, 2023	4	-$143K	4	Mar 3, 2023	EVP and Chief Legal Officer
EOLS	Evolus, Inc.	Jan 27, 2023	2	$0	4	Jan 31, 2023	Director
TNYA	Tenaya Therapeutics, Inc.	Sep 8, 2022	1	$0	4	Sep 9, 2022	Director
ANEB	Anebulo Pharmaceuticals, Inc.	Apr 21, 2022	1	$0	4	Oct 3, 2022	Director
RARE	Ultragenyx Pharmaceutical Inc.	Mar 7, 2022	1	-$324K	4	Mar 8, 2022	EVP and Chief Legal Officer
RARE	Ultragenyx Pharmaceutical Inc.	Mar 1, 2022	3	-$192K	4	Mar 3, 2022	EVP and Chief Legal Officer
EOLS	Evolus, Inc.	Jan 24, 2022	2	$0	4	Jan 26, 2022	Director
TNYA	Tenaya Therapeutics, Inc.	Dec 22, 2021	1	$0	4	Dec 23, 2021	Director
TNYA	Tenaya Therapeutics, Inc.	Dec 22, 2021	0	$0	3	Dec 23, 2021	Director
RARE	Ultragenyx Pharmaceutical Inc.	Oct 14, 2021	1	-$25.2K	4	Oct 18, 2021	EVP and General Counsel
RARE	Ultragenyx Pharmaceutical Inc.	Sep 8, 2021	3	-$339K	4	Sep 9, 2021	EVP and General Counsel
ARCT	Arcturus Therapeutics Holdings Inc.	Jun 18, 2021	1	$0	4	Jun 22, 2021	Director
RARE	Ultragenyx Pharmaceutical Inc.	Jun 10, 2021	1	-$133K	4	Jun 11, 2021	EVP and General Counsel
RARE	Ultragenyx Pharmaceutical Inc.	May 6, 2021	1	-$35.6K	4	May 10, 2021	EVP and General Counsel